Results 111 to 120 of about 6,469,838 (241)
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon +13 more
wiley +1 more source
Químics catalans al món: Pau Bernadó Peretó Centre de Biochimie Structurale de Montpeller (França) [PDF]
Bernadó Peretó, Pau
core
2025 update of the Greig Health Record: Part 2-what's controversial? [PDF]
Greig A +5 more
europepmc +1 more source
LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix +13 more
wiley +1 more source
Educació farmacèutica en els complements nutricionals a l’esport
Treballs d'Educació Farmacètica als ciutadans. Unitat Docent d'Estades en Pràctiques Tutelades. UCD: Tarragona i terres de l’Ebre. Facultat de Farmàcia, Universitat de Barcelona. Curs: 2014, Tutores: Montserrat Canela i Neus Caelles.
Bellés Obrero, Marta +3 more
core
L'allergie aux protéines du lait de vache chez les nourrissons et les enfants. [PDF]
Sathya P, Fenton TR.
europepmc +1 more source
Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla +10 more
wiley +1 more source

